Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
---|
02/09/2006 | US20060029829 Organometallic complexes as phosphorescent emitters in organic LEDS |
02/09/2006 | CA2576109A1 Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression |
02/09/2006 | CA2576073A1 Novel piperidine derivative for the treatment of depression |
02/09/2006 | CA2575329A1 Indole, indazole or indoline derivatives |
02/09/2006 | CA2574966A1 Isoindoline compounds and methods of their use |
02/09/2006 | CA2571789A1 Indoles having anti-diabetic activity |
02/08/2006 | EP1623985A2 Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventative agents |
02/08/2006 | EP1623976A1 Method for separation of optically active dihydroxy- heptenoic acid esters |
02/08/2006 | EP1623970A1 Arylamine compound and organic electroluminescence device containing the same |
02/08/2006 | EP1623712A2 Selective estrogen receptor modulator in combination with dehydroepiandrosterone (DHEA) or analogues |
02/08/2006 | EP1623223A2 Fluorescently tagged ligands |
02/08/2006 | EP1622895A2 1-aryl-3-(indol-5-yl)-prop-2-en-1-ones, compositions comprising the same and use thereof |
02/08/2006 | EP1622886A2 Substituted amino carboxylic acids as inhibitors of protein tyrosine phosphatase-1b |
02/08/2006 | EP1622865A2 Novel bioisosteres of actinonin |
02/08/2006 | EP1358162B1 Dihydroindole and tetrahydroquinoline derivatives |
02/08/2006 | EP1318978B1 N-acylsulfonamide apoptosis promoters |
02/08/2006 | CN1732161A 1,3-diamino-2-hydroxypropane pro-drug derivatives |
02/08/2006 | CN1732158A Indazole derivatives as CRF antagonists |
02/08/2006 | CN1732145A Chiral arylketones in the treatment of neutrophil-dependent inflammatory diseases |
02/08/2006 | CN1730481A 5-aza-indole preparation method |
02/08/2006 | CN1240700C Aromatic heterocyclic carboxylic acid derivative, preparing method and application in medicine |
02/08/2006 | CN1240681C Nitrile derivatives as cathepsin K inhibitors |
02/08/2006 | CN1240680C 1,4-pentadiene-3-ketone compound containing halogenoindyl, and method for preparing same and medicinal use thereof |
02/08/2006 | CN1240679C 2- and 2,5-substituted phenylketoenols |
02/08/2006 | CN1240677C Monofluoroalkyl derivatives |
02/08/2006 | CN1240388C Selective estrogen receptor modulator in combination with dehydroepiandrosterone or its derivative |
02/08/2006 | CN1240380C Phase transfer catalyzed glycosidation of an indolocarbazole |
02/07/2006 | USRE38970 Indolyl or indolinyl derivatives and medicinal use thereof as ACAT or lipid peroxidation inhibitors |
02/07/2006 | US6995284 Synthesis of selective androgen receptor modulators |
02/07/2006 | US6995274 Cyanine dyes |
02/07/2006 | US6995269 Guanidinobenzamides |
02/07/2006 | US6995184 Such as (7-chloro-2-methyl-1-(3-(methylsulphanyl)propyl)-1H-indol-3-yl)(2,3-dichloro-phenyl)methanone; cannabinoid receptors (cb2); G proteins coupled receptors |
02/07/2006 | US6995183 Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods |
02/07/2006 | US6995181 hyterocyclylaminomethyl- or aminocarbonyl-substituted 9,10-ethanoanthracenes or their aza derivatives; treating obesity, diabetes, inflammatory and immune disorders |
02/07/2006 | US6995180 for the treatment of diabetes, hyperglycemia, hypoglycemia, syndrome X, hyperinsulinemia, obesity, atherosclerosis, eating disorders, and nervous system disorders |
02/07/2006 | US6995176 1-heterocyclylalkyl-3-sulfonyl-indole or -indazole derivatives as 5-hydroxytryptamine-6 ligands |
02/02/2006 | WO2006012310A2 Carbazole derivatives for treating polycystic kidney disease |
02/02/2006 | WO2006012227A2 Amido compounds and their use as pharmaceuticals |
02/02/2006 | WO2006012162A2 Methods for producing and purifying 2-hydrocarbyl-3,3-bis(4-hydroxyaryl)phthalimidine monomers and polycarbonates derived therefrom |
02/02/2006 | WO2006011469A1 Novel cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes |
02/02/2006 | WO2006011035A1 Novel dipeptidyl peptidase iv inhibitors; process for their preparation and compositions containing them |
02/02/2006 | WO2006010965A1 Indole-2 -carboxamidine derivatives as nmda receptor antagonists |
02/02/2006 | WO2005032594A3 Alkylators linked to polyamides as dna binding agents |
02/02/2006 | US20060025601 Tricyclic indeno-pyrrole derivatives as serotonin receptor modulators |
02/02/2006 | US20060025596 Method for deuteration or tritiation of heterocyclic ring |
02/02/2006 | US20060025594 Small molecule entry inhibitors |
02/02/2006 | US20060025587 Process for the preparation of alpha-aminosubstituted carboxylic acid amides |
02/02/2006 | US20060025467 3-amino-1-arylpropyl indoles as monoamine reuptake inhibitors |
02/02/2006 | US20060025415 Compositions useful as inhibitors of voltage-gated sodium channels |
02/02/2006 | US20060025413 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors |
02/02/2006 | US20060025404 Such as 1-(4-{[1-(1-methylethyl)-4-piperidinyl]oxy}phenyl)-4-{[4-(methylsulfonyl)phenyl]carbonyl}piperazine; neurodegenerative disorders including Alzheimer's disease; allergic rhinitis |
02/02/2006 | US20060025402 Benzimidazolidinone derivatives as muscarinic agents |
02/02/2006 | US20060024775 Substrates for o6-alkylguanina-dna alkyltransferase |
02/02/2006 | DE112004000350T5 Organische Verbindung und organisches elektrolumineszierendes Element Organic compound and an organic electroluminescent element |
02/02/2006 | CA2574155A1 Indole-2 -carboxamidine derivatives as nmda receptor antagonists |
02/02/2006 | CA2573777A1 Novel cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes |
02/02/2006 | CA2570694A1 Amido compounds and their use as pharmaceuticals |
02/01/2006 | EP1620434A1 Fused bicyclic-substituted amines as histamine-3 receptor ligands |
02/01/2006 | EP1620422A2 Phenyl substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b |
02/01/2006 | EP1620420A2 Substituted carboxylic acids |
02/01/2006 | EP1620399A1 Indolone-acetamide derivatives, processes for preparing them and their uses |
02/01/2006 | EP1620398A1 Process for the preparation of indole derivatives by enzymatic acylation |
02/01/2006 | EP1620397A1 Hydroxamic acids useful in the treatment of hyper-proliferative disorders |
02/01/2006 | EP1620102A2 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands |
02/01/2006 | EP1620088A2 Indole acetic acid derivatives and their use as pharmaceutical agents |
02/01/2006 | EP1620087A1 Azabicyclo derivatives as muscarinic receptor antagonists |
02/01/2006 | EP1476419B1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives |
02/01/2006 | EP1104289B1 New oral formulation for 5-ht4 agonists or antagonists |
02/01/2006 | EP1080078B1 Heterocyclic compounds and methods to treat cardiac failure and other disorders |
02/01/2006 | CN1729197A Tetracyclic 3-substituted indoles having serotonin receptor affinity |
02/01/2006 | CN1729190A Pyridoindolone derivatives substituted in the 3-position by a phenyl, their preparation and their application in therapeutics |
02/01/2006 | CN1729181A Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
02/01/2006 | CN1729174A Synthesis of amines and intermediates for the synthesis thereof |
02/01/2006 | CN1729173A N-(indolethyl-) cacloamine compounds |
02/01/2006 | CN1729158A Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
02/01/2006 | CN1727339A Tricyclic compounds, their production and use |
02/01/2006 | CN1727332A Compound in category of aryl methylamino dithio formic ether, preparation method and application |
02/01/2006 | CN1239485C Benzophenones as inhibitors of IL-1 beta and TNF-alpha |
02/01/2006 | CN1239483C Preparation method of medicine intermediate gramine |
02/01/2006 | CN1239482C Positive modulators for nicotinic receptor agonists |
01/31/2006 | US6992101 indole and thieno (2,3-B)pyrrole compounds with 1,1-dioxo tetrahydro thiophene or pyran ring; treating diabetes, insulin resistance, diabetic neuropathy, diabetic nephropathy, hypertension, hyperinsulinemia, hyperlipidemia, ischemia |
01/31/2006 | US6992100 sPLA2 inhibitors |
01/26/2006 | WO2006010095A2 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors |
01/26/2006 | WO2006010082A1 1,4-disubstituted naphtalenes as inhibitors of p38 map kinase |
01/26/2006 | WO2006008250A2 Oxime derivatives and the use therof as latent acids |
01/26/2006 | WO2006007843A1 2-(1h-indolylsulfanyl) -aryl amine derivatives for use in the treatment of affective disorders, pain, adhd and stress urinary incontinence |
01/26/2006 | US20060020136 Phenylcarbazole compounds and organic electroluminescence devices using the same |
01/26/2006 | US20060020131 Aryl amide, -sulfonamide, or -urea derivatives; antiproliferative, antitumor, anticarcinogenic, and/or antimetastasis agents |
01/26/2006 | US20060020003 Biphenyloxy-acids |
01/26/2006 | US20060020002 (3a alpha ,4 alpha ,7 alpha ,7a alpha )-Octahydro-3-hydroxy-2-[4-nitro-3-(trifluoromethyl)phenyl]-4,7-methano-1H-isoindol-1-one (2); steroid mimic; competitive inhibitors of intercellular ligand binding reactions involving CAMs and Leukointegrins; anticarcinogenic agent; autoimmune diseases |
01/26/2006 | US20060019983 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists |
01/26/2006 | US20060019982 For therapy of central nervous system disorders, immunomodulatory disorders, antimalaria, viral disease of Borna virus, Hepatitis; a 6-azatricyclo(6.3.1.01,6)dodecane derivatives |
01/26/2006 | DE102004030900A1 Herstellung teilchenförmiger Peroxycarbonsäurezusammensetzungen Preparation of particulate Peroxycarbonsäurezusammensetzungen |
01/26/2006 | CA2574475A1 Indolone derivatives, processes for preparing them and their uses |
01/26/2006 | CA2574237A1 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof |
01/26/2006 | CA2574054A1 Oxime derivatives and the use therof as latent acids |
01/26/2006 | CA2573210A1 Viral polymerase inhibitors |
01/26/2006 | CA2573138A1 Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors |
01/26/2006 | CA2572047A1 Octahydropyrrolo[2,3,c]pyridine derivatives and pharmaceutical use thereof |
01/25/2006 | EP1619230A1 Red light emitting compounds for organic electroluminescent devices and organic electroluminescent devices using them |